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Abstract Animal mammary glands have been suc-
cessfully employed to produce therapeutic recombi-
nant human proteins. However, considerable variation
in animal mammary transgene expression efﬁciency
hasbeenreported.Wenowconsiderwhetheraspectsof
codon usage and/or protein tertiary structure underlie
this variation in mammary transgene expression.
Keywords Transgenic animal bioreactor  Codon
usage  Mammary gland  Tertiary structure
Introduction
The expression of functional proteins in heterologous
hosts is a cornerstone of modern biopharming. However,
many human proteins are often difﬁcult to express in
unicellular organisms such as bacterium and yeast. The
underlying problem is that codon bias has a profound
impactontheheterologousexpressionofhumanproteins
intheseorganisms.Codonusagehasbeenfoundtobethe
single most important factor in prokaryotic gene expres-
sion. Therefore laborious and time consuming codon
optimization is often necessa r yt oa c h i e v eas u c c e s s f u l
expression in unicellular organisms (Gustafsson et al.
2004). Contrary to unicellular organisms, no obvious
codon bias has been observed among human and several
other mammals in previous studies. Thus animal mam-
mary gland is considered an ideal bioreactor for produc-
ing functional human proteins without codon
optimization. With this concept in mind, a number of
transgenic livestock have been created to produce
different recombinant human proteins in their milk, and
in 2006 a recombinant human protein puriﬁed from a
transgenic goat was approved for clinical use in Europe
by the European Medicine Agency (Houdebine 2009).
However, considerable variation in expression efﬁ-
ciencyhas beenfound intheheterologuous expressions
of human proteins in the milk of transgenic animals
produced in our lab and other groups. Generally a
number of proteins such as serpin peptidase inhibitors
and immunoglobulins which are abundant in human
tissues other than mammary gland tend to exhibit a
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other humanproteinssuchasinterleukin-2,coagulation
factor 8 and catalase are difﬁcult to express in milk
(Wright et al. 1991;T a n ge ta l .2008; Buhler et al.
1990; Niemann et al. 1999;H ee ta l .2008a, b). These
examples cause us to question whether tissue speciﬁc
codon usage pattern affects translational regulation
during the heterologuous expression of human proteins
in animal mammary gland?
Recently several independent studies concluded
thatcodonbiasmightbeafactorinvolvedintranslation
regulation in humans. One study concluded that genes
selectively expressed in one human tissue can often be
discriminated from genes expressed in another tissue
on the basis of their synonymous codon usage (Plotkin
et al. 2004) while another study reported that the
amountoftRNAvarieswidelyamongdifferenthuman
tissues based on microarray results, further more they
showedthattherelativetRNAabundancesigniﬁcantly
correlates with codon usage of tissue speciﬁc genes
(Dittmar et al. 2006). The effective number of codons
(ENC) is a most common index for measurement of
codon bias. ENC is analogous to the effective number
of alleles in population genetics. However, ENC can
not reveal which codons are more frequent than others
but rather indicates the overall departure from random
synonymous codon choice. As a result, two genes may
exhibit the same degree of overall bias, but differ
dramatically in their particular choice of synonymous
codons. Thus in this study, we used a two-tailed Fisher
exact test to measure the distance of synonymous
codon usage between two genes (Plotkin et al. 2004).
Unlike metrics such as ‘‘relative synonymous codon
usage’’, which are noisy when applied to individual
genes,theFisherexacttestforsmallsamplesizesbased
codon usage measure can be applied to genes that
contain only a few examples of each amino acid.
We propose two scenarios: ﬁrst, the different
expression levels of recombinant human proteins in
the milk of transgenic animals is due to the variation
in synonymous codon usage patterns between mam-
mary gland and other human tissues; or, second,
protein tertiary structure may inﬂuence mammary
transgene expression.
Human and mouse tissue speciﬁc codon usage
We have made pair-wise comparisons of codon usage
among seven human tissues. When comparing heart
to kidney (Fig. 1), virtually all kidney associated
genes are clustered in a separate middle clade from
the heart associated genes. The observed separation
between these two classes of genes would not have
occurred by random chance (P\0.001). The
observed clustering is the result of systematic differ-
ential codon usage between heart and kidney speciﬁc
genes. Fig. 1 indicates that we can generally dis-
criminate between heart and kidney expressed genes
on the basis of their codon usage alone. Similarly,
kidney speciﬁc genes can be discriminated from lung
and pancreas speciﬁc genes (supplementary Fig. 1).
However, many pairs of tissue speciﬁc gene sets do
not exhibit signiﬁcantly different codon usage pat-
terns (e.g., brain versus pancreas, P = 0.384; sup-
plementary Fig. 2). Unexpectedly, in the tested six
mouse tissues, we can not observe any pair of tissues
that can be separated from each other on the basis of
their codon usage with a statistical signiﬁcant test.
Only heart speciﬁc genes can be nearly discriminated
from liver speciﬁc genes (P = 0.072; supplementary
Fig. 3).
When comparing human mammary gland to six
other tissues, only heart, lung and pancreas speciﬁc
genes can be discriminated from mammary gland
speciﬁc genes on the basis of codon usage (heart
versus mammary gland, P\0.001; lung versus
mammary gland, P = 0.002; pancreas versus mam-
mary gland, P\0.001; supplementary Fig. 4), and
the other three tissues in the test can not be
distinguished from mammary gland (brain versus
mammary gland, P = 0.368; kidney versus mam-
mary gland, P = 0.368; liver versus mammary gland,
P = 0.536; supplementary Fig. 5). In the tested six
mouse tissues, only genes selectively expressed in
heart and pancreas can be distinguished from mouse
mammary gland speciﬁc genes (heart versus mam-
mary gland, P = 0.002; pancreas versus mammary
gland, P = 0.038; supplementary Fig. 6). Thus there
does appear to be codon usage differences between
mammalian tissues.
Does expression levels of recombinant human
proteins in transgenic milk correlate
with mammary gland speciﬁc codon usage?
Successful examples of expressing recombinant
human proteins in transgenic animals to date are
summarized in Table 1 and the greatest expression
520 Transgenic Res (2010) 19:519–533
123level of the 31 recombinant proteins reported in
Table 1 were showed in Fig. 2. When comparing
codon usage of the 31 recombinant proteins
expressed in the milk of transgenic animals to human
mammary gland speciﬁc genes and milk proteins, we
found several most efﬁciently expressed recombinant
human proteins (SERPINC1, ATCD20IgL, REG3A,
LTF, FGA, FGB and FGG) were clustered close to
the mammary gland speciﬁc genes and milk proteins.
However, we also found the moderately expressed
FIX and those less efﬁciently expressed recombinant
proteins (LYZ, CAT, IL2 and mCol18a1) were
clustered close to most human mammary gland
speciﬁc genes and milk proteins. The observed three
classes of genes can not be discriminated from each
other (mammary gland, P = 0.574; milk proteins,
P = 0.900; supplementary Fig. 7). Similar results
can be observed in the comparing of recombinant
proteins to mouse mammary gland speciﬁc genes and
milk proteins (mammary gland, P = 0.952; milk
proteins, P = 0.974; supplementary Fig. 8). Further
comparing codon usage of milk proteins among 19
different mammals showed that most milk proteins
were prone to use similar codon usage patterns
Fig. 1 A dendogram
reﬂecting the codon usage
of 22 genes selectively
expressed in heart (red) and
17 genes selectively
expressed in human kidney
(black). The pairwise
distances underlying this
tree reﬂect the degree to
which the genes differ in
their codon usage. As this
tree demonstrates, heart-
speciﬁc genes can generally
be distinguished from heart-
speiciﬁc genes purely on the
basis of their synonymous
codon usage. The observed
separation between these
two classes of genes would
not have occurred by
random chance (P\0.001)
Transgenic Res (2010) 19:519–533 521
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123among different mammalian species (supplementary
Fig. 9). Thus we compared the codon usage of
recombinant proteins to milk proteins in the main
ﬁve livestock cow, sheep, goat, rabbit and pig. In
each animal, except for certain proteins, the cluster
result was quite similar to human and mouse (Fig. 3).
Thus we dismiss our proposal that expression
levels of recombinant human proteins in the milk of
transgenic animals correlate with mammary gland
speciﬁc codon usage patterns.
Recombinant human proteins with greater
expression levels in transgenic milk share similar
protein domains with milk proteins
The main domains of recombinant proteins expressed
in the milk of transgenic animals and mammalian
milk proteins derived from CATH were summarized
in Table 2. Casein makes up the main component of
milk proteins, as in bovine milk, it reaches as great as
82% of the total milk proteins (Jensen 1995). When
we investigated the main domains of the main four
caseins [casein alpha S1 (CSN1S1), casein alpha S2
(CSN1S2), casein beta (CSN2), and casein kappa
(CSN3)], it can be observed that all four caseins share
a similar alpha–beta based major domain (Fig. 4).
With the exception of CSN1S2 which is composed of
an alpha–beta barrel domain, the other three caseins
all are composed of a 3-layer (aba) sandwich shaped
major domain. Interestingly we found that within the
top 13 high level expressed recombinant proteins in
the milk of transgenic animals (expression level
35 mg/mL), 10 proteins share a similar alpha–beta
based major domain with casein proteins, especially
those with extra-higher expression levels such as
SERPINA1, SERPINC1, SERPING1, REG3A, LTF
and BCHE which all possess a 2-layer or 3-layer
(aba) sandwich shaped major domain similar to the
most abundant milk proteins CSN1S1, CSN2 and
CSN3. Beside the 10 high level expressed proteins,
there are another two proteins CEL (1.00 mg/mL)
and Calc1(2.10 mg/mL) each has a CSN2 like 3-layer
(aba) sandwich domain and mainly alpha beta
domain, respectively, though these two recombinant
proteins do not get an extra-higher expression levels
in the transgenic milk. However, the moderate
expression levels are probably due to their cDNA
based expression constructs. Because the gene struc-
ture used in an expression construct seems to have
T
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123signiﬁcant impact on expression level, generally a
genomic DNA sequence results in several orders of
magnitude greater expression level than a cDNA
sequence (Whitelaw et al. 1991).
Promoter plays a critical role at transcriptional
regulation of transgene expression. Milk protein gene
promoters must be used when expressing recombi-
nant proteins in animal mammary gland. Promoters
derived from j-casein and aS2-casein are particularly
weak (Houdebine 2000). In Table 1, none of the
reported studies used these two kinds of promoter.
Bovine aS1-casein, goat b-casein, mouse murine
acidic protein, and ovine b-lactoglobulin derived
promoters were most popularly used in these studies.
Under the regulation of ovine b-lactoglobulin pro-
moter and using genomic DNA of the foreign gene,
transgenic sheep expressed high level of SERPINA1
(35 mg/mL) and FIB (5 mg/mL) which both pos-
sessing major domains similar to caseins, whereas
lower level of FIX (1 mg/mL) which has a major
domain distinct with caseins. Similarly, under the
control of goat beta-casein promoter, transgenic goats
expressed high levels of SERPINC1 (20 mg/mL) and
SERPINA1 (14 mg/mL), whereas lower levels of
AFP (1.1 mg/mL) and tPA (3 mg/mL);furthermore,
under the control of bovine aS2-casein, transgenic
rabbits expressed high levels of SERPING1 (12 mg/
mL) and GAA (8 mg/mL), whereas lower levels of
tPA (0.05 mg/mL), NGF(0.25 mg/mL) and IGF1
(1 mg/mL). These cases may indicate protein struc-
ture appears to be an important factor affecting the
expression level of transgene in the mammary gland.
Taken together, we suggest that those recombinant
proteins share similar major domains to casein pro-
teins may have potential to achieve a greater
expression level in the milk of transgenic animals
when they are under similar transcriptional
regulation.
Materials and methods
Gene sequences analysis
Coding sequences of genes in this study were
obtained from GenBank. On the basis of BioGPS
(http://biogps.gnf.org/#goto=welcome) and several
other extensive mRNA expression microarray stud-
ies (Warrington et al. 2000; Hsiao et al. 2001;
Liang et al. 2006; Shyamsundar et al. 2005; Saito-
Hisaminato et al. 2002), we have identiﬁed genes
which are selectively expressed in human and
mouse mammary gland at lactation stage and in six
other tissues: human [mammary gland (13 genes),
brain (25 genes), heart (22 genes), kidney (17
genes), liver (26 genes), lung (19 genes) and
Fig. 2 Expression levels of recombinant human proteins in the
milk of transgenic animals. The expression level of each
protein presents the highest one among different studies
summarized in Table 1; ATCD20 IgH and ATCD20 IgL
indicate the heavy and light chain of human anti-CD20
monoclonal antibody; FGA, FGB and FGG note the alpha
chain, beta chain and gamma chain of ﬁbrinogen (FIB)
respectively; mCol18a1 stands for mouse collagen, type XVIII,
alpha 1; star notes the expression level of recombinant protein
with a cDNA based expression construct; open circle indicates
the expression level values of hFVIII(0.0027 mg/mL), hIL-
2(0.000043 mg/mL) and mCol18a1(0.00003 mg/mL) which all
are too low to be fully presented on the top of the bar
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123pancreas (27 genes; S1)] and mouse [mammary
gland (15 genes), brain (24 genes), heart (22 genes),
kidney (13 genes), liver (24 genes), lung (17 genes)
and pancreas (21 genes; S2)].
The sequences of animal milk protein genes
and recombinant proteins were summarized in
supporting materials Table S3 and Table S4
respectively.
Codon usage analysis
For this study, the distance of synonymous codon
usage between two genes were measured based on a
two-tailed Fisher exact test method (Plotkin et al.
2004). Brieﬂy, degree of codon bias in common sense
as the departure from random synonymous codon
choice is not concerned, but rather the degree to
Fig. 3 Dendograms reﬂecting the codon usage of milk
proteins of the main ﬁve livestock (red) and recombinant
proteins. The top 13 high level expressed recombinant proteins
(35 mg/mL) are showed in blue, and moderate and lower
expressed recombinant proteins are indicated in black. The
three classes of genes (indicated in three different colour) can
not be clearly discriminated from each other (cow, P = 0.992;
goat, P = 0.982; sheep, P = 0.992; rabbit, P = 0.962; pig,
P = 0.994)
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123Table 2 The main domains of recombinant proteins expressed in transgenic milk
Protein CATH Code Domain
IGF1 1.10.100.10 Mainly alpha; orthogonal bundle; insulin-like, subunit E; insulin-like, subunit E
AFP 1.10.246.10 Mainly alpha; orthogonal bundle; serum albumin; chain A, dDomain 1
ALB 1.10.246.10 Mainly alpha; orthogonal bundle; serum albumin; chain A, domain 1
LALBA 1.10.530.10 Mainly alpha; orthogonal bundle; lysozyme
LYZ 1.10.530.10 Mainly alpha; orthogonal bundle; lysozyme
EPO 1.20.1250.10 Mainly alpha; up-down bundle; growth hormone; chain: A;
GH
a 1.20.1250.10 Mainly alpha; up-down bundle; growth hormone; chain A
IL2 1.20.1250.10 Mainly alpha; up-down bundle; growth hormone; chain A
NGF 2.10.90.10 Mainly beta; ribbon; cystine knot cytokines, subunit B; cystine-knot cytokines
FIX 2.40.10.10 Mainly beta; beta barrel; thrombin, subunit H; trypsin-like serine proteases
FVII 2.40.10.10 Mainly beta; beta barrel; thrombin, subunit H; trypsin-like serine proteases
FVIII 2.40.10.10 Mainly beta; beta barrel; thrombin, subunit H; trypsin-like serine proteases
PROC 2.40.10.10 Mainly beta; beta barrel; thrombin, subunit H; trypsin-like serine proteases
tPA 2.40.10.10 Mainly beta; beta barrel; thrombin, subunit H; trypsin-like serine proteases
BLG 2.40.128.20 Mainly beta; beta barrel; lipocalin
CAT 2.40.180.10 Mainly beta; beta barrel; catalase HpII, chain A, domain 1
ATCD20IgH
a 2.60.40.10 Mainly beta; sandwich; immunoglobulin-like; immunoglobulins
ATCD21IgL
a 2.60.40.10 Mainly beta; sandwich; immunoglobulin-like; immunoglobulins
SOD3 2.60.40.200 Mainly beta; sandwich; immunoglobulin-like
mCol18a1
b 3.10.100.10 Alpha beta; roll; mannose-binding protein A, chain A; mannose-binding protein A, subunit A
REG3A
a,b 3.10.100.10 Alpha beta; roll; mannose-binding protein A, Chain A; mannose-binding protein A, subunit A
CSN1S2 3.20.20.70 Alpha beta; alpha–beta barrel; TIM Barrel; aldolase class I
GAA
a,b 3.20.20.80 Alpha beta; alpha–beta barrel; TIM barrel; glycosidases
SERPINA1
a,b 3.30.497.10 Alpha beta; 2-layer sandwich; antithrombin; chain I, domain 2; antithrombin, subunit I, domain 2
SERPINC1
a,b 3.30.497.10 Alpha beta; 2-layer sandwich; antithrombin; chain I, domain 2; antithrombin, subunit I, domain 2
SERPING1
a,b 3.30.497.10 Alpha beta; 2-layer sandwich; antithrombin; chain I, domain 2; antithrombin, subunit I, domain 2
LTF
a,b 3.40.190.10 Alpha beta; 3-layer(aba) sandwich; D-maltodextrin-binding protein; domain 2; periplasmic binding
protein-like II
CSN2 3.40.50.10150 Alpha Beta; 3-Layer(aba) Sandwich; Rossmann fold; Diol Dehydratase; Chain B
BCHE
a,b 3.40.50.1820 Alpha beta; 3-layer(aba) sandwich; rossmann fold
CEL
b,c 3.40.50.1820 Alpha beta; 3-layer(aba) sandwich; rossmann fold
CSN1S1 3.40.630.10 Alpha beta; 3-layer(aba) sandwich; aminopeptidase; Zn peptidases
CSN3 3.40.710.10 Alpha beta; 3-layer(aba) sandwich; beta-lactamase; DD-peptidase/beta-lactamase superfamily
FGA
a,b 3.90.215.10 Alpha beta; alpha–beta complex; gamma ﬁbrinogen; chain A, domain 1
FGB
a,b 3.90.215.10 Alpha beta; alpha–beta complex; gamma ﬁbrinogen; chain A, domain 1
FGG
a,b 3.90.215.10 Alpha beta; alpha–beta complex; gamma ﬁbrinogen; chain A, domain 1
Calc1
b,c 3.90.320.20 Alpha beta; alpha–beta complex; lambda exonuclease; chain A
WAP 4.10.75.10 Few secondary structures; irregular; R-elaﬁn; R-elaﬁn
The italic bold words note milk proteins
a The top 13 high level expressed recombinant proteins in the milk of transgenic animals (expression level35 mg/mL)
b The 13 recombinant proteins share similar domains with casein proteins
c The expression level was based on a cDNA construct
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123which genes differ in their encoding of amino acids is
concerned. Given the coding sequences for a pair of
genes, absolute frequency of each codon in each gene
is ﬁrst tabulated with condonW (http://codonw.source
forge.net//). For each amino acid, a two-tailed Fisher
exact test on the n 9 2 contingency table given by
the frequencies of the amino acid’s synonymous
codons is calculated (e.g., for Ser n = 4: TCA, TCC,
TCG, and TCT). As a result, for each amino acid a P-
value indicating whether or not the genes use sig-
niﬁcantly different codons to encode that amino acid
is obtained. For example, when comparing human
brain (25 genes) to heart (22 genes), distance between
codon usage of every pair of genes (including pairs
from the same tissue) is calculated, thus obtaining a
47-by-47 symmetric matrix of pairwise distances.
Distance between two genes is given by the number of
amino acids that exhibit signiﬁcantly different
(P\0.01) codon usage, as deﬁned above (detailed
SAS program was presented in supplementary mate-
rials S5). Then by using the neighbor joining method
(PHYLIP v3.66; http://evolution.gs.washington.edu/
phylip.html), a dendogram that graphically represents
the measured pairwise distances between the codon
usage in the study genes can be produced. To test
whether observed clustering of genes in a dendogram
is nonrandom, P value is calculated by comparing the
observed summed distances along the tree between
genes of the same tissue against a null distribution
produced by randomly permuting the labels of the
leaves.
Protein main domain analysis
Domains of recombinant proteins expressed in the
milk of transgenic animals and mammalian milk
proteins were evaluated with CATH (http://www.
cathdb.info/) which is a hierarchical classiﬁcation of
protein domain structures based on clustering pro-
teins at four major levels: Class (C), Architecture (A),
Topology (T) and Homologous superfamily (H).
Class is determined according to the secondary
structure composition and packing within the struc-
ture. Three major classes are recognized; mainly-
alpha, mainly-beta and alpha–beta. Architecture
describes the overall shape of the domain structure as
determined by the orientations of the secondary
structures but ignores the connectivity between the
Fig. 4 The tertiary
structures of the main
domains of casein proteins,
10 recombinant human
proteins highly expressed in
the milk of transgenic
animal, and two moderately
expressed proteins CEL
(1.00 mg/mL) and
Calc1(2.10 mg/mL) based
on cDNA expression
constructs. Figures were
made using VMD
(http://www.ks.uiuc.edu/
Research/vmd/) and ren-
dered using Snapshot
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123secondary structures. It is currently assigned manu-
ally using a simple description of the secondary
structure arrangement e.g. barrel or 3-layer sandwich.
Topology indicates that structure are grouped
according to whether they share the same topology or
fold in the core of the domain, that is, if they share
the same overall shape and connectivity of the sec-
ondary structures in the domain core. Homologous
superfamily groups together protein domains which
are thought to share a common ancestor and can
therefore be described as homologous. Similarities
are identiﬁed either by high sequence identity or
structure comparison using SSAP. Boundaries and
assignments for each protein domain are determined
using a combination of automated and manual pro-
cedures which include computational techniques,
empirical and statistical evidence, literature review
and expert analysis. Generally if a given protein chain
has sufﬁciently high sequence identity and structural
similarity (i.e. 80% sequence identity, SSAP score
C80) with a chain that has previously been chopped,
the domain boundary assignment is performed auto-
matically by inheriting the boundaries from the other
chain (ChopClose). Otherwise, the domain bound-
aries are assigned manually, based on an analysis of
results derived from a range of algorithms which
include structure based methods [CATHEDRAL,
SSAP, DETECTIVE (Swindells, 1995)], PUU (Holm
and Sander, 1994), DOMAK (Siddiqui and Barton,
1995), sequence based methods (Proﬁle HMMs) and
relevant literature.
How to improve mammary transgene
expression?
We suspect that it is not necessary to consider codon
usage optimization when targeting a human gene to
express in the animal mammary gland. So we
investigated the codon usage pattern between mam-
mary gland and other tissues. Signiﬁcant differences
were found between mammary gland with heart and
pancreas tissues both in human and mouse. However,
no signiﬁcant correlation was found between expres-
sion levels and codon usage of recombinant human
proteins expressed in the milk of transgenic animals.
This may indicate that even though a human gene
shares a similar codon usage with a mammary gland
speciﬁc gene, especially milk protein genes, does not
guarantee an effective expression in the mammary
gland. In contrast, those proteins which share a
similar domain with the four caseins are capable of
achieving higher expression levels in animal mam-
mary gland. We suppose that the tertiary structure of
a recombinant protein adapts to the synthesis and
secretion process of milk proteins especially caseins
may permit it to be efﬁciently expressed in animal
mammary gland.
In the secretory epithelial cell of mammary gland,
milk protein precursors are assembled on the ribo-
somes of the highly developed rough endoplasmic
reticulum (ER). All milk proteins have conserved
secretory signal peptide sequences, which lead the
growing nascent peptides to insert into the lumen of
the ER. The proteins are then transported to the Golgi
apparatus. The caseins then gradually intercalate with
each other, calcium and phosphate to form a submi-
cellar structures which lead to the formation of casein
micelles, ﬁnally secreted by reverse pinocytosis
(Farrell et al. 2006). Protein folding in the ER is
monitored by ER quality control (ERQC) mecha-
nisms. Proteins that pass ERQC criteria trafﬁc to their
ﬁnal destinations through the secretory pathway,
whereas non-native and unassembled subunits of
multimeric proteins are degraded by the ER-associ-
ated degradation (ERAD) pathway (Vembar and
Brodsky 2008). Overall, the environment of the ER
lumen would be conducive to the proper casein-
casein association, which helps them to escape
ERAD and move onto the Golgi for processing and
secretion. Thus the recombinant proteins as SERP-
INA1, SERPINC1, SERPING1 and BCHE, which
have compact spherical structures composed of
mainly alpha beta, 2-lalyer or 3-layer sandwich like
domains, presumably form self-association or interact
with caseins through the conserved structural ele-
ments, and escape the ERAD, and are efﬁciently
transported to the Golgi apparatus to assemble
micelles, and ultimately efﬁciently secreted into
milk, lead to a high expression level in the transgenic
milk. In contrast, AFP, CAT, FIX, IL2, NGF, and tPA
all have a mainly alpha or beta barrel based domain
which is quite different from casein (Supplementary
Fig. 10). They may not interact with caseins properly
and are aggregated to evoke the ERAD, thus fail to
trafﬁc to the Golgi apparatus, and ultimate lead to
less efﬁcient expression in the milk of transgenic
animals.
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123Today it is still difﬁcult to exactly predict the
expression efﬁciency of one transgenic animal biore-
actor. Because the expression efﬁciency of mammary
transgene relies on a series of complex molecular
regulation and cellular process. And it may be animal
species dependent. Protein tertiary structuremay bean
important factor affecting the expression of animal
mammary transgene. We doubt this is an absolute
factor but, for example, for those proteins failing to
secrete into transgenic milk even after transcriptional
optimization, we might need to pay more attention to
their tertiary structures. We may need to generate a
group of elaborately designed gene targeting mice
expressing structural distinct proteins under similar
transcriptional regulation to verify this hypothesis.
Furthermore, if for mammary transgenes encoding
proteins that are structurally distinct from caseins such
that they may pass through the ER/Golgi-dependent
classical secretion pathway inefﬁciently, raises engi-
neering the non-classical secretary pathway (He et al.
2008a, b; Nickel 2003) as an intriguing option.
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